171 related articles for article (PubMed ID: 2219668)
21. Evidence that proteolytic separation of Shiga-like toxin type IIv A subunit into A1 and A2 subunits is not required for toxin activity.
Samuel JE; Gordon VM
J Biol Chem; 1994 Feb; 269(7):4853-9. PubMed ID: 7906271
[TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
MacLeod DL; Gyles CL
Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
[TBL] [Abstract][Full Text] [Related]
23. The role of adhesive F107 fimbriae and of SLT-IIv toxin in the pathogenesis of edema disease in pigs.
Imberechts H; de Greve H; Hernalsteens JP; Schlicker C; Bouchet H; Pohl P; Charlier G; Bertschinger HU; Wild P; Vandekerckhove J
Zentralbl Bakteriol; 1993 Apr; 278(2-3):445-50. PubMed ID: 8102270
[TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II.
Downes FP; Green JH; Greene K; Strockbine N; Wells JG; Wachsmuth IK
J Clin Microbiol; 1989 Jun; 27(6):1292-7. PubMed ID: 2666439
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice.
Tesh VL; Burris JA; Owens JW; Gordon VM; Wadolkowski EA; O'Brien AD; Samuel JE
Infect Immun; 1993 Aug; 61(8):3392-402. PubMed ID: 8335369
[TBL] [Abstract][Full Text] [Related]
26. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
[TBL] [Abstract][Full Text] [Related]
27. Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin.
Franke S; Harmsen D; Caprioli A; Pierard D; Wieler LH; Karch H
J Clin Microbiol; 1995 Dec; 33(12):3174-8. PubMed ID: 8586696
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli.
Karch H; Meyer T
J Clin Microbiol; 1989 Jun; 27(6):1180-6. PubMed ID: 2666436
[TBL] [Abstract][Full Text] [Related]
29. Cloning and sequence analysis of another Shiga-like toxin IIe variant gene (slt-IIera) from an Escherichia coli R107 strain isolated from rabbit.
Kim SH; Cha IH; Kim KS; Kim YH; Lee YC
Microbiol Immunol; 1997; 41(10):805-8. PubMed ID: 9403506
[TBL] [Abstract][Full Text] [Related]
30. Production of a Shiga-like cytotoxin by Campylobacter.
Moore MA; Blaser MJ; Perez-Perez GI; O'Brien AD
Microb Pathog; 1988 Jun; 4(6):455-62. PubMed ID: 3193876
[TBL] [Abstract][Full Text] [Related]
31. Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine.
Bosworth BT; Samuel JE; Moon HW; O'Brien AD; Gordon VM; Whipp SC
Infect Immun; 1996 Jan; 64(1):55-60. PubMed ID: 8557374
[TBL] [Abstract][Full Text] [Related]
32. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay.
Perera LP; Marques LR; O'Brien AD
J Clin Microbiol; 1988 Oct; 26(10):2127-31. PubMed ID: 3053764
[TBL] [Abstract][Full Text] [Related]
33. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.
Louise CB; Obrig TG
J Infect Dis; 1995 Nov; 172(5):1397-401. PubMed ID: 7594687
[TBL] [Abstract][Full Text] [Related]
34. Reproduction of edema disease of swine with purified Shiga-like toxin-II variant.
MacLeod DL; Gyles CL; Wilcock BP
Vet Pathol; 1991 Jan; 28(1):66-73. PubMed ID: 1826800
[TBL] [Abstract][Full Text] [Related]
35. Toxigenic Escherichia coli in Spanish piggeries from 1986 to 1991.
Garabal JI; Gonzalez EA; Vazquez F; Blanco J; Blanco M
Vet Microbiol; 1995 Nov; 47(1-2):17-25. PubMed ID: 8604549
[TBL] [Abstract][Full Text] [Related]
36. Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome.
Rüssmann H; Kothe E; Schmidt H; Franke S; Harmsen D; Caprioli A; Karch H
J Med Microbiol; 1995 Jun; 42(6):404-10. PubMed ID: 7791204
[TBL] [Abstract][Full Text] [Related]
37. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.
Tesh VL; Ramegowda B; Samuel JE
Infect Immun; 1994 Nov; 62(11):5085-94. PubMed ID: 7927791
[TBL] [Abstract][Full Text] [Related]
38. Effects of human intravenous immune globulin on diarrhea caused by Shiga-like toxin I and Shiga-like toxin II in infant rabbits.
Havens PL; Dunne WM; Burd EM
Microbiol Immunol; 1992; 36(10):1077-85. PubMed ID: 1479962
[TBL] [Abstract][Full Text] [Related]
39. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
Perera LP; Samuel JE; Holmes RK; O'Brien AD
J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
[TBL] [Abstract][Full Text] [Related]
40. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
